星空体育官方入口网站网址大全-登录入口官网

#艾曲波帕#

17篇内容 | 1087人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2178581, encodeId=e8be21e8581b1, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a> <a href='/topic/show?id=fbd825321ba' target=_blank style='color:#2F92EE;'>#他克莫司#</a> <a href='/topic/show?id=e40f109494af' target=_blank style='color:#2F92EE;'>#复发/难治性获得性再生障碍性贫血#</a> <a href='/topic/show?id=049c1094951a' target=_blank style='color:#2F92EE;'>#前瞻性随机试验#</a>, objectTitle=Blood Cancer J：艾曲波帕联合或不联合他克莫司治疗复发/难治性获得性再生障碍性贫血的疗效比较, objectType=article, longId=807622, objectId=e12c80e622d2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894721657_4754896.jpeg, objectUrl=/article/show_article.do?id=e12c80e622d2, replyNumber=0, likeNumber=56, createdTime=2024-01-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e12c80e622d2, moduleTitle=Blood Cancer J：艾曲波帕联合或不联合他克莫司治疗复发/难治性获得性再生障碍性贫血的疗效比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e12c80e622d2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1420139, encodeId=acc3142013926, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Am J Hematol；骨髓衰竭患者长期使用艾曲波帕治疗会导致铁耗竭, objectType=article, longId=301942, objectId=176130194273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=176130194273, replyNumber=0, likeNumber=123, createdTime=2022-03-31, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=176130194273, moduleTitle=Am J Hematol；骨髓衰竭患者长期使用艾曲波帕治疗会导致铁耗竭, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=176130194273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420138, encodeId=c5701420138ca, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=BJH：免疫性血小板减少症成人在接受艾曲波帕或罗米司亭治疗后改用阿凡波帕：一项多中心美国研究, objectType=article, longId=299453, objectId=052e29945346, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=052e29945346, replyNumber=0, likeNumber=73, createdTime=2022-02-24, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=052e29945346, moduleTitle=BJH：免疫性血小板减少症成人在接受艾曲波帕或罗米司亭治疗后改用阿凡波帕：一项多中心美国研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=052e29945346)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420137, encodeId=833d142013ed4, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=NEJM：免疫抑制疗法加用艾曲波帕治疗重度再生障碍性贫血, objectType=article, longId=293587, objectId=845229358ea2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=845229358ea2, replyNumber=0, likeNumber=66, createdTime=2022-01-09, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=845229358ea2, moduleTitle=NEJM：免疫抑制疗法加用艾曲波帕治疗重度再生障碍性贫血, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=845229358ea2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420136, encodeId=ea66142013604, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=AJH：艾曲波帕治疗单倍体相同外周血干细胞移植后持续性血小板减少症患者, objectType=article, longId=220708, objectId=5e53220e080d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e53220e080d, replyNumber=0, likeNumber=64, createdTime=2021-11-22, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e53220e080d, moduleTitle=AJH：艾曲波帕治疗单倍体相同外周血干细胞移植后持续性血小板减少症患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5e53220e080d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420135, encodeId=a0d2142013546, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性, objectType=article, longId=219573, objectId=1bc72195e3c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bc72195e3c8, replyNumber=0, likeNumber=66, createdTime=2021-11-02, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bc72195e3c8, moduleTitle=Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1bc72195e3c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420134, encodeId=b3d514201344a, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Int J Hematol：罗米布司汀可有效治疗艾曲波帕难治性再生障碍性贫血, objectType=article, longId=214202, objectId=1c69214202fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c69214202fe, replyNumber=0, likeNumber=59, createdTime=2021-07-15, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c69214202fe, moduleTitle=Int J Hematol：罗米布司汀可有效治疗艾曲波帕难治性再生障碍性贫血, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1c69214202fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420133, encodeId=603c1420133b3, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Leukemia：艾曲波帕eltrombopag在骨髓增生异常综合征的PDX模型中的临床前评估, objectType=article, longId=213632, objectId=794621363207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=794621363207, replyNumber=0, likeNumber=54, createdTime=2021-07-03, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=794621363207, moduleTitle=Leukemia：艾曲波帕eltrombopag在骨髓增生异常综合征的PDX模型中的临床前评估, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=794621363207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420132, encodeId=1d6a14201328d, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Blood：艾曲波帕治疗继发于LPDs的ITP, objectType=article, longId=180492, objectId=553818049234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=553818049234, replyNumber=0, likeNumber=109, createdTime=2019-10-05, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=553818049234, moduleTitle=Blood：艾曲波帕治疗继发于LPDs的ITP, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=553818049234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420131, encodeId=493c142013191, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Blood：艾曲波帕（EPAG）与难治性重度再生障碍性贫血（rSAA）, objectType=article, longId=164530, objectId=cbd616453097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbd616453097, replyNumber=0, likeNumber=118, createdTime=2019-04-20, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbd616453097, moduleTitle=Blood：艾曲波帕（EPAG）与难治性重度再生障碍性贫血（rSAA）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cbd616453097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420130, encodeId=4d57142013088, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Blood：艾曲波帕（eltrombopag）可在IFNγ介导的炎性环境中维持人造血干/祖细胞的存活和功能, objectType=article, longId=163408, objectId=1a0e163408e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a0e163408e3, replyNumber=0, likeNumber=62, createdTime=2019-04-03, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a0e163408e3, moduleTitle=Blood：艾曲波帕（eltrombopag）可在IFNγ介导的炎性环境中维持人造血干/祖细胞的存活和功能, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1a0e163408e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420129, encodeId=bdde1420129fc, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Blood：阿扎胞苷疗法联合艾曲波帕治疗MDS患者，会恶化其血小板减少, objectType=article, longId=150825, objectId=7a6715082543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6715082543, replyNumber=0, likeNumber=70, createdTime=2018-10-13, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6715082543, moduleTitle=Blood：阿扎胞苷疗法联合艾曲波帕治疗MDS患者，会恶化其血小板减少, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7a6715082543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420128, encodeId=39b614201284d, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性, objectType=article, longId=116645, objectId=eb9611664500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb9611664500, replyNumber=0, likeNumber=113, createdTime=2017-10-20, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb9611664500, moduleTitle=Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=eb9611664500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420127, encodeId=e47e142012ecc, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=NEJM：添加艾曲波帕的免疫抑制治疗有望成为重症再生障碍性贫血一线治疗方案, objectType=article, longId=96684, objectId=92b89668455, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92b89668455, replyNumber=0, likeNumber=102, createdTime=2017-04-23, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92b89668455, moduleTitle=NEJM：添加艾曲波帕的免疫抑制治疗有望成为重症再生障碍性贫血一线治疗方案, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=92b89668455)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420126, encodeId=1d0e142012651, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=Lacnet：艾曲波帕对慢性免疫性血小板减少症儿童患者是有效的, objectType=article, longId=57745, objectId=932f5e74566, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=932f5e74566, replyNumber=0, likeNumber=81, createdTime=2015-10-26, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=932f5e74566, moduleTitle=Lacnet：艾曲波帕对慢性免疫性血小板减少症儿童患者是有效的, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=932f5e74566)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420125, encodeId=54a21420125f3, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=FDA扩大了艾曲波帕片在ITP中的使用年龄, objectType=article, longId=55869, objectId=04d05586965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04d05586965, replyNumber=0, likeNumber=66, createdTime=2015-09-09, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04d05586965, moduleTitle=FDA扩大了艾曲波帕片在ITP中的使用年龄, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=04d05586965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420124, encodeId=3c7e1420124bd, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=FDA:GSK的艾曲波帕（eltrombopag）用于再生障碍性贫血可能获审批, objectType=article, longId=31048, objectId=18f0310481d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18f0310481d, replyNumber=0, likeNumber=67, createdTime=2014-02-24, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18f0310481d, moduleTitle=FDA:GSK的艾曲波帕（eltrombopag）用于再生障碍性贫血可能获审批, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=18f0310481d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1420123, encodeId=f354142012347, content=<a href='/topic/show?id=7a7286e7153' target=_blank style='color:#2F92EE;'>#艾曲波帕#</a>, objectTitle=NEJM:艾曲波帕可改善难治性再生障碍性贫血, objectType=article, longId=7686, objectId=8c74e686e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c74e686e4, replyNumber=0, likeNumber=102, createdTime=2012-07-08, rootId=0, userName=huangdf, userId=776e3562469, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c74e686e4, moduleTitle=NEJM:艾曲波帕可改善难治性再生障碍性贫血, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8c74e686e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

艾曲波帕

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#艾曲波帕# #他克莫司# #复发/难治性获得性再生障碍性贫血# #前瞻性随机试验#

Blood Cancer J：艾曲波帕联合或不联合他克莫司治疗复发/难治性获得性再生障碍性贫血的疗效比较

2024-01-01发表于上海

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Am J Hematol；骨髓衰竭患者长期使用艾曲波帕治疗会导致铁耗竭

2022-03-31

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

BJH：免疫性血小板减少症成人在接受艾曲波帕或罗米司亭治疗后改用阿凡波帕：一项多中心美国研究

2022-02-24

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

NEJM：免疫抑制疗法加用艾曲波帕治疗重度再生障碍性贫血

2022-01-09

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

AJH：艾曲波帕治疗单倍体相同外周血干细胞移植后持续性血小板减少症患者

2021-11-22

zhaojie88 (审核中...)

前往app查看评论内容

#艾曲波帕#

Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性

2021-11-02

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Int J Hematol：罗米布司汀可有效治疗艾曲波帕难治性再生障碍性贫血

2021-07-15

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Leukemia：艾曲波帕eltrombopag在骨髓增生异常综合征的PDX模型中的临床前评估

2021-07-03

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Blood：艾曲波帕治疗继发于LPDs的ITP

2019-10-05

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Blood：艾曲波帕（EPAG）与难治性重度再生障碍性贫血（rSAA）

2019-04-20

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Blood：艾曲波帕（eltrombopag）可在IFNγ介导的炎性环境中维持人造血干/祖细胞的存活和功能

2019-04-03

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Blood：阿扎胞苷疗法联合艾曲波帕治疗MDS患者，会恶化其血小板减少

2018-10-13

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Blood：Eltrombopag（艾曲波帕）用于ITP成年患者的长期安全性和有效性

2017-10-20

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

NEJM：添加艾曲波帕的免疫抑制治疗有望成为重症再生障碍性贫血一线治疗方案

2017-04-23

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

Lacnet：艾曲波帕对慢性免疫性血小板减少症儿童患者是有效的

2015-10-26

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

FDA扩大了艾曲波帕片在ITP中的使用年龄

2015-09-09

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

FDA:GSK的艾曲波帕（eltrombopag）用于再生障碍性贫血可能获审批

2014-02-24

huangdf (审核中...)

前往app查看评论内容

#艾曲波帕#

NEJM:艾曲波帕可改善难治性再生障碍性贫血

2012-07-08

科室
- - 订阅+
  - 更多科室
工具
服务